• 1. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
• 2. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 3. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 4. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
• 5. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Medium-chain fatty acids
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acids and conjugates Medium-chain fatty acids

CAS No. 30361-33-2: (2E,4E)-2,4-Decadienoic Acid - A Key Bioactive Compound in Modern Biomedical Research

CAS No. 30361-33-2, also known as (2E,4E)-2,4-Decadienoic Acid, represents a critical class of polyunsaturated fatty acids (PUFAs) that have garnered significant attention in recent years for their multifaceted roles in cellular signaling, metabolic regulation, and therapeutic applications. This compound is a naturally occurring member of the omega-6 fatty acid family, characterized by its conjugated double bond structure (2E,4E configuration) and its presence in various biological systems. Recent advancements in lipidomics and molecular biology have further elucidated its physiological significance, making it a focal point for researchers exploring its potential in disease prevention and treatment.

As a conjugated dienoic acid, (2E,4E)-2,4-Decadienoic Acid exhibits unique chemical properties that distinguish it from other fatty acids. Its conjugated double bonds create a planar structure that facilitates interactions with membrane-bound receptors and signaling molecules. This structural feature is critical for its biological activity, as it enables the compound to modulate lipid rafts, influence membrane fluidity, and participate in redox reactions. Studies published in Nature Communications (2023) have demonstrated that this compound can alter the dynamics of cell membranes, thereby affecting ion channel function and intracellular signaling pathways. These findings highlight its potential as a therapeutic agent in conditions involving membrane dysfunction, such as neurodegenerative disorders and cardiovascular diseases.

(2E,4E)-2,4-Decadienoic Acid is a key component of the omega-6 fatty acid family, which includes well-known compounds like linoleic acid and arachidonic acid. However, its specific biological role remains distinct due to its unique molecular configuration. Recent research in Cell Metabolism (2022) has shown that this compound plays a pivotal role in the biosynthesis of bioactive lipid mediators, such as hydroxyeicosatetraenoic acids (HETEs) and epoxyeicosatrienoic acids (EETs). These metabolites are involved in regulating inflammation, vascular tone, and immune responses, underscoring the importance of (2E,4E)-2,4-Decadienoic Acid in maintaining physiological homeostasis.

The CAS No. 30361-33-2 compound has also been implicated in the regulation of lipid metabolism and metabolic syndrome. A study published in Journal of Lipid Research (2023) revealed that this fatty acid can modulate the expression of genes involved in lipid storage and oxidation, potentially offering new therapeutic strategies for obesity and type 2 diabetes. Furthermore, its ability to interact with peroxisome proliferator-activated receptors (PPARs) suggests a role in metabolic reprogramming, which is a key area of focus in modern pharmacology.

In the context of biomedical research, (2E,4E)-2,4-Decadienoic Acid has emerged as a promising candidate for drug development. Its involvement in inflammatory responses and immune modulation has led to investigations into its potential as an anti-inflammatory agent. For instance, a 2024 study in Science Translational Medicine demonstrated that this compound can inhibit the activation of nuclear factor-kappa B (NF-κB), a key transcription factor in inflammation. This finding opens new avenues for the treatment of chronic inflammatory diseases, such as rheumatoid arthritis and inflammatory bowel disease.

Additionally, the CAS No. 30361-33-2 compound has been linked to neurological disorders due to its role in synaptic plasticity and neuroinflammation. Research published in Neuron (2023) highlighted its ability to protect neurons from oxidative stress, suggesting potential applications in neurodegenerative conditions like Alzheimer's disease and Parkinson's disease. These findings are particularly significant given the growing global burden of neurological disorders and the need for novel therapeutic interventions.

The synthetic and natural sources of (2E,4E)-2,4-Decadienoic Acid are also areas of active research. While this compound is naturally present in plant oils and animal tissues, its synthetic production has been optimized to meet the demands of pharmaceutical and industrial applications. Advances in biotechnology, such as microbial fermentation and enzymatic synthesis, have enabled the scalable production of this compound. These developments are crucial for ensuring its availability for clinical trials and commercial use.

Furthermore, the toxicological profile of CAS No. 30361-33-2 is an important consideration for its therapeutic application. While preliminary studies suggest that this compound is relatively safe at low concentrations, its long-term effects require further investigation. A 2023 review in Toxicological Sciences emphasized the need for rigorous safety assessments to ensure that its use in therapeutic contexts does not lead to unintended side effects. This underscores the importance of translational research in bridging the gap between laboratory findings and clinical applications.

In conclusion, (2E,4E)-2,4-Decadienoic Acid (CAS No. 30361-33-2) is a multifunctional fatty acid with profound implications for biology and medicine. Its unique chemical structure and biological activities position it as a valuable target for further research and development. As our understanding of its mechanisms continues to evolve, the potential applications of this compound in disease prevention and treatment are expected to expand, offering new hope for patients with a wide range of conditions.

For researchers and pharmaceutical companies, the study of CAS No. 30361-33-2 represents an opportunity to explore innovative therapeutic strategies. By leveraging its biological properties, scientists can develop targeted interventions that address the underlying mechanisms of various diseases. This compound's role in lipid metabolism, inflammation, and neurological function highlights its significance as a key player in the field of biomedical research. As such, continued investment in this area is likely to yield groundbreaking discoveries and therapeutic advancements in the years to come.

Ultimately, the CAS No. 30361-33-2 compound exemplifies the intersection of chemistry, biology, and medicine. Its unique properties and potential applications underscore the importance of interdisciplinary research in advancing human health. As the scientific community continues to unravel the complexities of this compound, its impact on the field of biomedical research is expected to grow, paving the way for new treatments and interventions that address some of the most pressing health challenges of our time.

• 1871-67-6(trans-2-Octenoic Acid)
• 18999-28-5(2-Heptenoic acid)
• 1289-45-8(Dodecenoic acid)
• 72881-27-7(Milk lactone)
• 3760-11-0(2-Nonenoic acid)
• 128397-09-1(Benzo[3,4]-18-norandrosta-3,5,15-triene-3(2'H)-carboxylicacid,3',4',5',6'-tetrahydro-3'-hydroxy-15-(hydroxymethyl)-3',4',9,14,17,17-hexamethyl-,(3b,3'a,4b,4'a,8a,9b,10a,13a,14b)-)
• 10352-88-2(hept-2-enoic acid)
• 15790-94-0(trans-2-Undecenoic acid)
• 1470-50-4(oct-2-enoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)